Three decades of surgical excellence, academic leadership at Yale, and nationally recognized patient outcomes define Dr.

(“LSA”), investment adviser to The Private Shares Fund (the “Fund,” PRIVX, PIIVX, PRLVX), announces a shift in its portfolio following the landmark acquisition of xAI by SpaceX on February 2, 2026.

I think we're better positioned now as a company than we have ever been in the history of Advanced Energy,” CEO Steve Kelley said during the company’s earnings call on Tuesday.

Novocure (NASDAQ: NVCR) announced today that the U.S. Food and Drug Administration (FDA) approved Optune Pax ® for the treatment of adult patients with locally advanced pancreatic cancer concomitant ...